Our Pricing

Buy Mounjaro Single Pen - All Doses Available

When you buy Mounjaro single pen UK online through Cured Pharmacy, you gain access to all licensed doses with transparent upfront pricing from £145. Our UK-registered clinical team provides free consultations under three minutes, ensuring you receive the appropriate tirzepatide dose for your weight management journey with complete discretion and regulatory compliance.

How Mounjaro Tirzepatide Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced metabolic effects that regulate appetite, slow gastric emptying, and improve insulin sensitivity.

In the landmark SURPASS-3 clinical trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly superior to comparator treatments [1]. The dual-receptor mechanism appears to produce additive benefits beyond GLP-1 activation alone, though individual responses vary based on baseline metabolic health, adherence, and lifestyle modifications.

Each Mounjaro KwikPen delivers a precise subcutaneous dose once weekly, administered into the abdomen, thigh, or upper arm. The medication works gradually, with most patients experiencing progressive appetite reduction and weight loss over several months when combined with a reduced-calorie diet and increased physical activity [2].

Available Mounjaro Doses and Titration Schedule

Mounjaro is available in six dose strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg per pen. The MHRA-approved titration protocol begins with 2.5mg weekly for four weeks, then increases to 5mg for the next four weeks [3]. Your UK prescriber will determine subsequent dose escalations based on your weight loss response and tolerability, with increases occurring at four-week intervals until reaching your optimal maintenance dose.

The gradual titration schedule minimises gastrointestinal side effects — the most common adverse reactions reported in clinical trials. Starting at lower doses allows your body to adapt to tirzepatide's effects on gastric emptying and appetite regulation before progressing to higher therapeutic doses [3].

Most patients achieve their maintenance dose between 10mg and 15mg weekly, though some may find adequate efficacy at lower doses. Your prescriber will review your progress regularly and adjust dosing accordingly, ensuring you receive the minimum effective dose for your individual needs.

Why Single Pen Purchasing Offers Flexibility

Purchasing Mounjaro as single pens rather than multi-pen packs provides greater flexibility during dose titration. As you progress through increasing dose strengths every four weeks, single-pen purchasing ensures you only pay for the specific dose prescribed at each stage, avoiding waste and unnecessary upfront costs for doses you may not require.

At Cured Pharmacy, transparent pricing means you see the exact cost for each dose strength before completing your clinical assessment. This approach aligns with our commitment to lowest prices guaranteed and allows you to budget accurately throughout your treatment journey.

Mounjaro Pricing and How to Buy Single Pens Online

Mounjaro single pens start from £145 at Cured Pharmacy, with pricing varying by dose strength. Our transparent pricing structure shows all costs upfront — before you complete your free online consultation — ensuring no hidden fees or unexpected charges. All prices include the medication, UK prescriber assessment, and discreet delivery to your chosen address.

To buy Mounjaro single pen UK online, you'll complete a brief clinical questionnaire reviewed by our UK-registered prescribers. The assessment takes under three minutes and covers your medical history, current medications, weight management goals, and any contraindications. If approved, your prescription is issued electronically and dispensed by our GPhC-registered pharmacy (registration number 9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073).

Delivery is discreet, with no external branding indicating pharmacy or medication contents. Most orders are dispatched within 24 hours of prescription approval, arriving via Royal Mail or courier service depending on your location and selected delivery option.

Lowest Prices Guaranteed in the UK

Cured Pharmacy guarantees the lowest Mounjaro prices in the UK. If you find a lower price from another UK-registered pharmacy for the same dose, we'll match it. Our purchasing agreements with licensed wholesalers and efficient online-only model allow us to offer genuine UK-licensed Mounjaro at prices significantly below traditional high-street pharmacies.

All Mounjaro supplied by Cured Pharmacy is sourced exclusively through MHRA-approved channels, ensuring authenticity and proper cold-chain storage. We never supply grey-market or unlicensed imports, maintaining the highest standards of pharmaceutical safety and regulatory compliance.

Comparing Mounjaro to Other Weight Loss Treatments

When considering weight loss injections, UK patients typically compare Mounjaro (tirzepatide) with Wegovy (semaglutide) and Saxenda (liraglutide). All three are MHRA-licensed GLP-1 receptor agonists, though Mounjaro's dual GIP/GLP-1 mechanism distinguishes it from the single-pathway alternatives [1][4].

Head-to-head trials demonstrate tirzepatide's superior efficacy in average weight reduction compared to semaglutide. In the SURPASS-2 study, participants on 15mg tirzepatide lost significantly more weight than those on 1mg semaglutide over 40 weeks [4]. However, individual responses vary, and some patients may achieve excellent results with semaglutide-based treatments at lower cost.

Saxenda requires daily injections rather than weekly administration, which some patients find less convenient. Orlistat-based treatments like Xenical work through a completely different mechanism — blocking fat absorption rather than regulating appetite hormones — and typically produce more modest weight loss of 5-10% when combined with dietary changes [5].

Choosing Between Injectable and Oral Options

Injectable treatments like Mounjaro generally produce greater average weight loss than oral medications such as Orlistat or Mysimba. The subcutaneous delivery method ensures consistent absorption and bioavailability, whereas oral medications must pass through the digestive system and may have variable absorption rates.

Your UK prescriber will consider your medical history, weight loss goals, injection tolerance, and budget when recommending the most appropriate treatment. All prescription weight loss medications require ongoing lifestyle modifications including reduced-calorie diet and increased physical activity to achieve optimal results.

Common Side Effects and Safety Considerations

The most frequently reported side effects of Mounjaro in clinical trials were gastrointestinal: nausea (affecting up to 30% of participants), diarrhoea, vomiting, constipation, and abdominal discomfort [1]. These effects typically occur during dose titration and diminish over time as your body adapts to the medication. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms.

More serious but rare adverse effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3]. The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Before prescribing Mounjaro, your UK clinician will review your complete medical history, including any history of pancreatitis, diabetic retinopathy, kidney disease, or eating disorders. Pregnant or breastfeeding women should not use tirzepatide, and the medication should be discontinued at least two months before planned conception due to the long elimination half-life [3].

Maximising Results: Lifestyle Modifications with Mounjaro

Clinical trial results for Mounjaro reflect outcomes achieved when medication is combined with comprehensive lifestyle interventions including reduced-calorie diet (typically 500-calorie daily deficit) and increased physical activity (at least 150 minutes of moderate exercise weekly) [1]. The medication is not a standalone solution but rather a pharmacological tool that reduces appetite and enhances satiety, making dietary adherence more achievable.

Successful long-term weight management requires sustainable behavioural changes. Focus on nutrient-dense whole foods, adequate protein intake (1.2-1.6g per kilogram body weight to preserve lean muscle during weight loss), and regular resistance training to maintain metabolic rate. Many patients find that Mounjaro's appetite-suppressing effects make portion control and healthy food choices significantly easier than previous unassisted attempts.

Your prescriber may recommend working with a registered dietitian or enrolling in a structured weight management programme to optimise outcomes. Regular monitoring of weight, waist circumference, and metabolic markers helps track progress and allows dose adjustments as needed. Most clinical guidelines suggest continuing treatment as long as patients achieve at least 5% weight loss within the first 12-16 weeks and maintain therapeutic benefits [6].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. Retrieved from https://www.medicines.org.uk/emc/product/14298
4. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet, 398(10300), 583-598. https://doi.org/10.1016/S0140-6736(21)01443-4
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155
6. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating overweight and obesity [TA1007]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta1007

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment combined with lifestyle modifications including reduced-calorie diet and increased physical activity.